Atlas’ stealth-stage company will leverage AbCellera’s technology to start and advance new drug programs with enhanced speed and capital efficiency VANCOUVER, BC & CAMBRIDGE, MASS.– AbCellera (Nasdaq: ABCL) and Atlas Venture announced a… Read More
IMscin001 study showed non-inferior levels of cancer immunotherapy Tecentriq in the blood, when injected subcutaneously, compared to intravenous infusion, in people with advanced non-small cell lung cancer Administered under the skin, the… Read More
A multidisciplinary study led by Vanja Nagy (LBI-RUD/CeMM/Medical University of Vienna) and Josef Penninger (UBC/IMBA) characterized a novel gene, known as FIBCD1, to be likely causative of a new and… Read More
Acquire knowledge and skills in the practical aspects of biomedical device development. Gain industry-relevant training in project planning and economic management, intellectual property and regulatory frameworks, and effective and inclusive… Read More
The Canadian B2B SaaS Market Accelerator will help 10 Canadian startups evaluate and prepare for expansion into the Washington state and the United States markets. This virtual accelerator will last… Read More
